Caxton Associates (New York)’s Aterian ATER Stock Holding History
Bought
Maintained
Sold
Other funds holding ATER
AC
SM
PVH
SFM
Caxton Associates (New York)'s ATER Position: Q2 2021 in Review
Caxton Associates (New York) sold out of Aterian (ATER) in Q2 2021, closing a stake of 1,333 shares — an estimated $472K sold.
Caxton Associates (New York) first reported a position in ATER in Q1 2021 and held it in 1 quarter. The position peaked at $472K in Q1 2021. 82 funds tracked by Wall St. Rank hold ATER as of Q2 2021.
- Caxton Associates (New York) reported no remaining Aterian position as of Q2 2021 after selling out during the quarter.
- Caxton Associates (New York) sold 1,333 Aterian shares in Q2 2021, an estimated $472K.
- Caxton Associates (New York) first reported a position in Aterian in Q1 2021 and held it in 1 quarter.
- Caxton Associates (New York)'s Aterian position peaked at $472K in Q1 2021.
- 82 funds tracked by Wall St. Rank held Aterian as of Q2 2021.
Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.